1-3 of 3
Casey L. O'Connell
Close
Sort by
Journal Articles

Guadecitabine vs TC in relapsed/refractory AML after intensive chemotherapy: a randomized phase 3 ASTRAL-2 trial

Clinical Trials & Observations
Gail J. Roboz, Guillermo Sanz, Elizabeth A. Griffiths, Karen Yee, Hagop Kantarjian, Christian Récher, Michael T. Byrne, Elżbieta Patkowska, Hee-Je Kim, Xavier Thomas, Ine Moors, Wendy Stock, Árpád Illés, Pierre Fenaux, Yasushi Miyazaki, Takahiro Yamauchi, Casey L. O'Connell, Yong Hao, Harold N. Keer, Mohammad Azab, Hartmut Döhner
Journal: Blood Advances
Blood Adv (2024) 8 (8): 2020–2029.
https://doi.org/10.1182/bloodadvances.2023012062
Published: 2024
Includes: Supplemental data
Journal Articles

Burnout in US hematologists and oncologists: impact of compensation models and advanced practice provider support

Alfred Ian Lee, Leah E. Masselink, Laura M. De Castro, Ariela L. Marshall, Nathan T. Connell, Georgette A. Dent, Josel Fritz, Morgan Homer, Tiffany L. Lucas, Rakhi P. Naik, Marquita Nelson, Casey L. O’Connell, Anita Rajasekhar, Robby J. Reynolds, Deva Sharma, Melody Smith, Lachelle D. Weeks, Clese E. Erikson
Journal: Blood Advances
Blood Adv (2023) 7 (13): 3058–3068.
https://doi.org/10.1182/bloodadvances.2021006140
Published: 2023
Includes: Supplemental data
Journal Articles

Associations between hematology/oncology fellows’ training and mentorship experiences and hematology-only career plans

Leah E. Masselink, Clese E. Erikson, Nathan T. Connell, Laura M. De Castro, Georgette A. Dent, Ariela L. Marshall, Rakhi P. Naik, Marquita Nelson, Casey L. O’Connell, Anita Rajasekhar, Deva Sharma, Melody Smith, Alfred Ian Lee
Journal: Blood Advances
Blood Adv (2019) 3 (21): 3278–3286.
https://doi.org/10.1182/bloodadvances.2019000569
Published: 2019
Includes: Supplemental data